Involvement of HisF in the persistence of "Acinetobacter baumannii" during a pneumonia infection by Martínez-Guitián, Marta et al.
BRIEF RESEARCH REPORT
published: 29 August 2019
doi: 10.3389/fcimb.2019.00310







Vanderbilt University, United States
Luis R. Martinez,





†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Molecular Bacterial Pathogenesis,
a section of the journal
Frontiers in Cellular and Infection
Microbiology
Received: 05 June 2019
Accepted: 15 August 2019
Published: 29 August 2019
Citation:
Martínez-Guitián M,
Vázquez-Ucha JC, Álvarez-Fraga L,
Conde-Pérez K,
Lasarte-Monterrubio C, Vallejo JA,
Bou G, Poza M and Beceiro A (2019)
Involvement of HisF in the Persistence
of Acinetobacter baumannii During a
Pneumonia Infection.
Front. Cell. Infect. Microbiol. 9:310.
doi: 10.3389/fcimb.2019.00310
Involvement of HisF in the
Persistence of Acinetobacter
baumannii During a Pneumonia
Infection
Marta Martínez-Guitián †, Juan C. Vázquez-Ucha †, Laura Álvarez-Fraga †,
Kelly Conde-Pérez, Cristina Lasarte-Monterrubio, Juan Andrés Vallejo, Germán Bou,
Margarita Poza*† and Alejandro Beceiro †
Servicio de Microbiología Do Complexo Hospitalario Universitario da Coruña (CHUAC), Instituto de Investigación Biomédica
da Coruña (INIBIC), Universidade da Coruña (UDC), A Coruña, Spain
Acinetobacter baumannii is currently considered one of themost problematic nosocomial
microorganisms. In the present work the hisF gene from the ATCC 17978 strain and the
AbH12O-A2 clinical isolate of A. baumannii was found over-expressed during the course
of murine pneumonia infections. The study demonstrated that the A. baumannii ATCC
17978 mutant strain lacking the hisF gene induces a sub-lethal pneumonia infection
in mice, while the complemented mutant strain increased its virulence. This histidine
auxotroph mutant showed an increase on IL-6 secretion and leukocytes recruitment
during infections. Furthermore, data revealed that the hisF gene, implicated in the innate
immunity and inflammation, is involved in virulence during a pneumonia infection, which
may partly explain the ability of this strain to persist in the lung. We suggest that HisF,
essential for full virulence in this pathogen, should be considered a potential target for
developing new antimicrobial therapies against A. baumannii.
IMPORTANCE
Nosocomial pathogens such as A. baumannii are able to acquire and develop multi-drug
resistance and represent an important clinical and economic problem. There is therefore
an urgent need to find new therapeutic targets to fight against A. baumannii. In the
present work, the potential of HisF from A. baumannii as a therapeutic target has
been addressed since this protein is involved in the innate inmunity and the inflamatory
response and seems essential to develop a pneumonia in mice. This work lays the
groundwork for designing antimicrobial therapies that block the activity of HisF.
Keywords: HisF, mice pneumonia model, lung infection, Acinetobacter baumannii, virulence
INTRODUCTION
Acinetobacter baumannii is included in a list published by the WHO of the most important
antibiotic-resistant bacteria (World Health Organization, 2017). This species shows a high capacity
to persist in hospital environments and to develop antimicrobial resistance. There is therefore
an urgent need to find new therapeutic targets for designing novel strategies for fighting against
this pathogen.
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The hisF gene of A. baumannii is involved in histidine and
de novo purine biosynthesis. The hisH and hisF products shape
the heterodimeric protein imidazole glycerol phosphate (ImGP)
synthase. This heterodimeric enzyme catalyzes transformation
of the intermediate N′-(5′-phosphoribosyl)-formimino-5-
aminoimidazol-4-carboxamide ribonucleotide (PRFAR) into
5′-(5-aminoimidazole-4-carboxamide) ribonucleotide (AICAR)
and ImGP, which are further used in de novo purine and histidine
biosynthesis, respectively (Figure S1).
One of the products of HisF, AICAR, an analog of
adenosine monophosphate (AMP), is capable of stimulating
AMP-activated protein kinase (AMPK) activity. Both AICAR
monophosphate and AMP, which are small molecules, trigger a
conformational change in the AMPK complex that allows further
activation by phosphorylation of Thr-172 (Kim et al., 2016).
The AMPK enzyme, the central regulator of energy homeostasis,
participates in the cellular response to metabolic stress and
is considered an important therapeutic target for controlling
different human diseases (Kim et al., 2016). Once activated,
AMPK phosphorylates numerous metabolic enzymes, causing
global inhibition of biosynthetic pathways and activation of
catabolic pathways and thus generating and conserving energy
(Ruderman et al., 2003). As well as stimulating AMPK, AICAR
can also inhibit the lipopolysaccharide-induced production of
proinflammatory cytokines (Giri et al., 2004). Treatment with
an adenosine kinase inhibitor was able to block the ability of
AICAR to activate AMPK, preventing inhibition of inflammation
in mice mesangial cells (Jhun et al., 2004; Peairs et al.,
2009). Other authors have also described the role of AICAR
in regulating inflammation (Giri et al., 2004; Jhun et al., 2004;
Peairs et al., 2009).
In the present study, we found that the hisF gene was over-
expressed in the lungs of mice with pneumonia caused by the
ATCC 17978 strain and the multiresistant AbH12O-A2 clinical
isolate of A. baumannii. The aim of the study was to investigate
the involvement of the hisF gene in the pathogenesis of A.
baumannii by using in vitro and in vivo assays.
MATERIALS AND METHODS
Microbial Strains and Culture Conditions
A. baumannii ATCC 17978 and its mutant derivative strains, as
well as the AbH12O-A2 clinical isolate of A. baumannii and E.
coli TG1 (Table 1) were routinely grown or maintained in Luria-
Bertani (LB) or Mueller-Hinton (MH) media supplemented
with 2% agar when necessary. All strains were grown at 37◦C
and stored at −80◦C in LB broth with 10% glycerol. When
appropriate, cultures were supplemented with kanamycin (km)
at a final concentration of 50 mg/L (Sigma-Aldrich, USA).
Determination of the hisF Gene Expression
An experimental model of pneumonia in mice was used
to describe the transcriptome of the ATCC 17978 and the
multiresistant AbH12O-A2 clinical strains of A. baumannii
during the course of infection, as previously reported (Álvarez-
Fraga et al., 2018). Briefly, BALB/c male mice were intratracheally
inoculated with ∼6 × 107 bacteria per mouse. Bronchoalveolar
TABLE 1 | Bacterial strains and plasmids used in this study.




ATCC 17978 Clinical isolate ATCC*
1hisF A1S_3245 gene (hisF )
deletion mutant obtained from
















AbH12O-A2 Multiresistant clinical isolate,
which caused a large
nosocomial outbreak
Merino et al., 2014;
Pérez et al., 2017
E. coli
TG1








pWH1266-Km-hisF pWH1266-Km harboring the
A1S_hisF gene; KmR
This study
pMo130 Suicide vector for the
construction of A. baumannii
isogenic derivative; KmR,
SacB, XylE
Hamad et al., 2009
*American Type Culture Collection.
lavage (BAL) was performed at 20 h to obtain bacteria for RNA
extraction (in vivo samples). RNA extracted from bacteria grown
in LB medium was used as an experimental control (in vitro
samples). Total RNA was used for RNAseq analysis (Illumina,
Biogune, Spain). Reads from each mRNA library were obtained
using HiScanSQ (Illumina Inc., CIC bioGUNE, Bilbao, Spain).
Gene expression analysis was done at CIC bioGUNE’s genome
analysis platform (Derio, Spain). Raw data were deposited in the
GEO database with the accession code GSE100552 (document
named GSE100552_ATCC_ODvsATCC _raton.tsv.gz).
Construction of the Isogenic Mutant Strain
The hisF gene was identified as A1S_3245 in the first genome
sequence of A. baumannii ATCC 17978 (CP000521) (Fernando
et al., 2014) and later annotated as AU097_05240 in a recent
genome sequence of this strain (CP018664.1). The isogenic
mutant strain (1hisF), lacking the hisF gene, was derived from
the A. baumannii ATCC 17978 strain by double crossover
recombination using the suicide vector pMo130 (Genbank:
EU862243), as previously described (Álvarez-Fraga et al., 2016).
Briefly, the 1hisF isogenic mutant derivative was constructed
by deleting a fragment of the A1S_3245 gene. The upstream
and downstream regions flanking the A1S_3245 gene were
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 August 2019 | Volume 9 | Article 310
Martínez-Guitián et al. HisF From A. baumannii in Murine Pneumonia
PCR-amplified and cloned into the vector pMo130 using the
primers shown in Table S1. The construction obtained was used
to transform wild type cells by electroporation. Recombinant
colonies were selected as previously described (Álvarez-Fraga
et al., 2016). The second crossover event was checked by PCR
using primers listed in Table S1.
Complementation of the Mutant Strain
In order to obtain the complemented strain, the A1S_3245 gene
was PCR-amplified from the genome of the ATCC 17978 strain
and cloned into vector pWH1266-Km using the primers shown
in Table S1. The pWH1266-Km plasmid was constructed as
previously described (Hamad et al., 2009; Álvarez-Fraga et al.,
2016). The genetic construction obtained was used to transform
the 1hisF isogenic mutant strain. The complemented 1hisF
mutant strain was selected in kanamycin-containing plates.
The ATCC 17978 and the 1hisF strains harboring the empty
pWH1266-Km vector were used as experimental controls.
Biofilm Formation Assay
Biofilm formation ability was assessed as described by Tomaras
et al. (2003) and modified by Álvarez-Fraga et al. (2016).
Briefly, cells of A. baumannii centrifuged from an overnight
culture were washed and resuspended in LB medium. Then,
samples were stagnant incubated at 37◦C for 48 h. Growth was
monitored at OD600nm and the amount of biofilm formed was
quantified by crystal violet staining using ethanol-acetone. The
OD580nm/OD600nm ratio was used to normalize the amount of
biofilm formed to the total cell content of each sample.
Adhesion to A549 Human Alveolar
Epithelial Cells
The ability of the strains to adhere to A549 human epithelial
cells was evaluated as described by Gaddy et al. (2009) and
modified by Álvarez-Fraga et al. (2016). Briefly, A549 human cells
were grown at 37◦C and 5% CO2 in Dulbecco modified Eagle
medium (DMEM) (Sigma-Aldrich) containing 1% of penicillin-
streptomycin (Fisher Scientific, UK) and 10% of fetal bovine
serum.Monolayers were washed with HBSS (Hank’s balanced salt
solution, Fisher Scientific) without glucose (mHBSS). A549 cells
(1 × 105 cells/well) were then infected with 107 bacteria in 24-
well plates and incubated for 3 h inmHBSS at 37◦C. Finally, A549
cells were washed and lysed with sodium deoxycholate. Lysates
were plated and incubated at 37◦C for 24 h. Colony forming
units (CFUs) were counted to determine the number of bacteria
adhered to cells.
Growth Curve Analysis
Fitness was assessed by measuring the growth rates of the ATCC
17978 strain, the isogenic mutant strain 1hisF, the ATCC 17978
+ pWH1266-Km, the 1hisF + pWH1266-Km, and the 1hisF
mutant strain complemented as described before. Briefly, 1.5ml
of LB medium was inoculated with ∼5 × 107 CFU of each
strain, previously grown until the stationary phase, and incubated
at 37◦C with shaking. Growth was monitored in an Epoch
2 Microplate Spectrophotometer (BioTek Instruments, Inc.)
and OD600nm values were recorded every 20min as previously
described (Álvarez-Fraga et al., 2018).
Growth curves were also performed to demonstrate the
histidine auxotrophy of the 1hisF mutant. To perform these
assays, 10 × 105 CFUs/well of the ATCC 17978 strain and
the isogenic mutant strain 1hisF were grown in M9 minimal
medium in presence or absence of 0.5mM of histidine. Cultures
were inoculated as above described. Samples were collected at 3,
6, 24, and 48 h and the number of viable bacteria present in the
medium was checked by colonies counting in LB agar plates.
Determination of A549 Cells Survival
Infected With A. baumannii Strains
An experimental model of infection of A549 human alveolar
epithelial cells was used to study the in vitro virulence of A.
baumannii strains as previously described (González-Bello et al.,
2015). Briefly, cells were cultured in DMEM suplemented with
10% fetal bovine serum and 1% of penicillin-strptomycin. Later,
1 × 105 cells per well were infected with 5 × 107 CFUs of
parental and 1hisF mutant strain and incubated 20 h at 37◦C.
The number of inoculated bacteria was determined by direct
plating. A LIVE/DEAD fluorescence microscopy kit (Cellstain
Double-staining Kit; Fluka, Switzerland) was used according to
the manufacturer’s instructions to measure cell viability post-
infection. The A549 cells were incubated for 15min at 37◦C with
the two fluorescent molecules to obtain simultaneous fluorescent
staining; calcein-AM, to stain viable cells (green), and propidium
iodide, to stain only dead cells (red). Microscopic images of
the stained cells were obtained using an inverted fluorescence
microscope (Nikon Eclipse Ti) and analyzed with the NIS
Elements Br software package.
Susceptibility Testing
Antimicrobial susceptibility analyses, done by the disk
diffusion method, were performed using ampicillin, cefoxitin,
ceftazidime, cefepime, imipenem, tigecycline, rifampicin,
colistin, ciprofloxacin, and gentamicin disks (Sigma-Aldrich)
(Clinical and Laboratory Standards Institute, 2018).
Murine Pneumonia Model
A murine pneumonia model was used to examine the role of
the hisF gene in in vivo virulence. Briefly, BALB/c mice were
intratracheally inoculated with 40 µL of a bacterial suspension
containing 3 × 109 CFU/mL sterile saline solution and 10%
of porcine mucin (wt/vol) (Sigma-Aldrich) mixed at 1:1 ratio
(Álvarez-Fraga et al., 2018).
To ascertain the relevance of the hisF gene in virulence using
a murine pneumonia model, a second assay was performed to
determine the bacterial burden in lungs. Groups of 8 mice were
intratracheally inoculated, as above described, with ATCC 17978
wild type and 1hisF mutant strains. Mice were sacrificed at 20 h
and lung samples were obtained and processed as previously
described (Rodríguez-Hernández et al., 2000).
Murine Sepsis Model
A murine sepsis model was also constructed using BALB/c
mice. Mice were inoculated intraperitoneally with 100 µL of a
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bacterial suspension containing 75× 107 CFU/mL, as previously
described (Beceiro et al., 2014). The survival rate was assessed
during 7 days post-infection.
Galleria mellonella Infection Model
The virulence of the ATCC 17978 wild type and 1hisF mutant
strains was assessed using a Galleria mellonella infection model
as previously described (Álvarez-Fraga et al., 2018). Briefly,
G. mellonella caterpillars (Bio Systems Technology, UK) were
infected with 2× 104 bacteria and incubated at 37◦C in the dark.
Death was determined every 8 h during 6 days to obtain the larval
survival rates.
IL-6 Production Determination
Cell-free supernatants from infected RAW 264.7 cells and from
BAL fluid from infected mice were used to analyse cytokine IL-
6. RAW 264.7 macrophages were grown at 37◦C and 5% CO2
in DMEMmedium (Sigma-Aldrich) containing 10% fetal bovine
serum and 1% penicillin-streptomycin (Fisher Scientific). An
amount of 1 × 105 RAW 264.7 cells per well were infected with
3.5 × 107 CFU of the parental or mutant strains using 24-well
plates. Cell supernatants were collected at 2, 6, and 20 h post-
infection, centrifuged at 1,000x g for 10min and stored at−80◦C
prior to IL-6 production determination.
BAL fluids from lungs ofmice infected as above described with
the wild type or the mutant strain were extracted at 6 and 24 h
after the challenge. A protease inhibitor cocktail was added and
immediately centrifuged at 1,000x g for 10 min.
IL-6 was measured in both macrophages and lung samples by
ELISA using the Murine IL-6 ELISA Kit (Diaclone, France) as
previously described (Alnahas et al., 2017).
Leukocyte Counts
In the murine pneumonia model, BAL fluid was obtained 6
and 24 h after the challenge, to determine the total leukocyte
cell counts. Cells were fixed and stained with Diff-Quick
Stain (Thermo-Scientific, USA). Counts were performed using
a microscope (Olympus, Japan) and the software cellSens
Dimension (Olympus).
Phagocytic Assays
The phagocytic activity was assessed against the A. baumannii
strains used in this study. RAW 264.7 murine cells were
maintained in DMEM supplemented with 10% fetal bovine
serum and 1% of penicillin-streptomycin. Macrophages were
activated RAW 264.7 during 3 days in presence of phorbol 12-
myristate 13-acetate (PMA, Sigma-Aldrich) at 100 nM. Then
macrophages RAW 264.7 were scraped and seeded into 48-
well plates (4 × 104 cells/well). Bacterial strains were cultured
in LB or LB with 50 mg/L of kanamycin at 37◦C until 0.7
OD600nm, washed twice in saline solution and adjusted at 10 ×
106 CFU/mL in DMEM + 10% FBS. Additionally, AICAR at
1mM was added to the 1hisF mutant and incubated 30min at
room temperature. Infections were performed adding 200 µL of
bacterial inoculum to each well with cells and incubated 1 h at
37◦C. Finally, supernatants were aspirated and plated onto LB
or LB plus kanamycin plates. The determination of phagocytosis
activity was calculated by comparison with control wells with
bacterial inoculum without the presence of macrophages.
Statistical Analysis
A student’s t-test was used to evaluate the statistical significance
of the observed differences in all assays, except in the survival
assays, in which the survival curves were plotted by the Kaplan-
Meier method and analyzed with the log-rank test. Differences
were considered statistically significant at p ≤ 0.05. All assays
were performed at least in triplicate.
Ethics Statement
All experiments with mice were performed in accordance with
regulatory guidelines and standards established by the Animal
Ethics Committee (CHUAC, Spain, project code P82).
RESULTS AND DISCUSSION
Expression analysis of the hisF gene was performed using the A.
baumannii ATCC 17978 strain, one of the best-studied strains of
this species, and the multiresistant AbH12O-A2 clinical isolate,
that caused more than 300 colonizations/infections in a hospital
in Madrid, Spain (Merino et al., 2014; Pérez et al., 2017).
Transcriptomic analysis using RNAseq Illumina procedures
revealed that, relative to bacteria grown in vitro, the hisF gene
was over-expressed in both the ATCC 17978 (7.2-fold) and the
AbH12O-A2 clinical (19.2-fold) A. baumannii strains, causing
lung infection in mice.
Expression of other genes involved in histidine biosynthesis
was also checked. The pathway of histidine biosynthesis is
complex and involves nine genes (hisG, hisI, hisE, hisA, hisF,
hisH, hisB, hisC, and hisD) (Fani et al., 1998). Among these
genes, only hisF was found to be over-expressed during the
lung infection, in both the ATCC 17978 and the AbH12O-A2
clinical strains. A key step occurs when the formation of two
products is catalyzed by the heterodimeric enzyme complex
ImGP synthase, which consists of hisH and hisF. One of the
products, ImGP, is further used in histidine biosynthesis, and
the other, AICAR, is used in de novo synthesis of purines and
AMPK activation (Fani et al., 1998; O’Donoghue et al., 2001)
(Figure S1). Thus, AICAR synthesis mainly depends on HisH
and HisF. The mechanism whereby HisH produces ammonia
(NH3) from glutamine involves hydrolysis to release NH3 and
glutamate (Chittur et al., 2001). The sequential HisH and HisF
reactions are strongly coupled in order to facilitate the necessary
transfer of NH3 to the HisF active site and to produce ImGP
and AICAR. In our in vivo transcriptomic analysis, we detected
over-expression of the hisF gene whereas the expression level
of the hisH gene remained unaltered. The different speed of
reaction of these enzymes could explain the relevance of HisF in
AICAR production and in virulence during the lung infection.
Thus, it has been demonstrated that a 5,300-fold increase in
basal glutamine hydrolysis produced by HisH is observed in
the presence of the substrate PRFAR (Myers et al., 2003). In
this case, over-expression of hisH may not be as important as
over-expression of hisF for increasing the AICAR synthesis.
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An isogenic mutant strain lacking hisF gene (1hisF)
derived from the ATCC 17978 strain was constructed in
order to investigate the function of hisF. No significant
differences between the ATCC 17978 strain and its derivate
isogenic mutant 1hisF were observed in biofilm formation or
capacity for adherence to A549 human alveolar epithelial cells
(Figures S2A,B). There was also no difference in growth rate
between the parental and the 1hisF mutant strain (Figure S2C)
or in the survival rate of human alveolar epithelial A549 cells
infected with the mutant and the wild type strains (Figure S2D).
No changes in susceptibility to any of the tested antimicrobials
were detected when the hisF gene was deleted (Table S2).
Remarkably, the murine pneumonia model showed that the
survival rate of mice infected with the 1hisF mutant strain was
significantly higher than that of mice infected with the parental
strain (p < 0.001, Figure 1A). The lack of the hisF gene led
to an important loss of virulence in the A. baumannii ATCC
17978 strain. Conversely, no such differences were observed
in the murine sepsis or in the G. mellonella infection models
(Figure S3). When bacterial burden in lungs was analyzed at
20 h, results confirmed the relevant decrease of virulence in the
experimental murine pneumonia. The lungs of mice infected
with the 1hisF mutant showed two logarithms less bacterial
burden than those infected with the parental strain (p <
0.01, Figure S4).
Then, complementation of the mutant strain with the
A1S_3245 gene (1hisF complemented strain) was performed by
expressing the hisF gene from the pWH1266-Km vector. In a
parallel assay, virulence of both the mutant and the parental
strains harboring the empty plasmid and the mutant containing
the plasmid harboring the hisF gene were analyzed using
the murine pneumonia model. No significant differences were
observed between the A. baumannii wild type strain harboring
the empty pWH1266-Km vector and the 1hisF mutant strain
complemented. However, the virulence of the 1hisF mutant
strain complemented was higher than that of the 1hisF mutant
strain harboring the empty plasmid (p < 0.05, Figure 1B).
Overall the data indicated that the hisF gene expressed from
the plasmid partly restored the wild type phenotype. It should
be noted that carrying the pWH1266-Km plasmid implies an
important metabolic load to the bacterium, which affects its
growth rate and its fitness (Álvarez-Fraga et al., 2018). As
shown in Figure S2C, the strains carrying the pWH1266-Km
plasmid decreased their fitness, which, in turn, affects their
virulence. Therefore, the survival rate of mice infected with
strains harboring the pWH1266-Km plasmid was higher than
that of mice infected with strains without plasmids, for the
same bacterial inoculum. However, as shown in Figure S2C
no fitness differences were observed between the ATCC 17978
and the 1hisF strains or between the ATCC 17978 carrying
pWH1266-Km, the 1hisF mutant strain carrying pWH1266-Km
and the 1hisF mutant strain complemented. Thus, the decreased
virulence of 1hisF mutants in murine pneumonia assays is
exclusively attributable to the inactivation of hisF gene and not
to the presence/absence of the pWH1266-Km plasmid.
The transformation of PRFAR by HisF produces AICAR,
used in de novo purine biosynthesis and ImGP, used in histidine
FIGURE 1 | Survival rate of mice in a pneumonia model (N = 10). (A) The
parental ATCC 17978 and the mutant 1hisF A. baumannii strains. Survival
was significantly higher in mice infected with the 1hisF mutant (p < 0.01).
(B) The ATCC 17978 + pWH1266-Km (empty plasmid), the 1hisF +
pWH1266-Km, and the complemented 1hisF A. baumannii strains. Survival
was significantly lower in mice infected with the complemented than in the
1hisF strain harboring the empty plasmid (p < 0.05). There were no significant
differences in survival between mice infected with ATCC 17978 +
pWH1266-km and 1hisF complemented strains.
biosynthesis (Figure S1). Purine nucleotides can be synthesized
trough two distinct pathways. First, purines can be synthesized
de novo, attaching a formyl group to AICAR to produce IMP
(inosine monophosphate) and later AMP and GMP (guanosine
monophosphate). Alternatively, purine bases can be salvaged
and recycled by the hydrolytic degradation of nucleic acids and
nucleotides. However, to synthetize histidine the HisF protein
and ImGP are essential. Thus, histidine auxotrophy assays were
performed to demonstrate the implication of A1S_3245 in
AICAR and ImGP production. As reflected in Figure S5, while
the ATCC 17978 strain was able to grow inM9minimal medium,
the 1hisF mutant strain was unable to grow, decreasing the
number of viable bacteria at 24 h. The addition of 0.5mM of
histidine to the M9 medium does not affected the growth rate
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FIGURE 2 | (A) Amount of IL-6 at 2, 6, and 20 h post-infection in the cell-free
supernatant of macrophages RAW 264.7 (N = 5) infected with the parental
ATCC 17978 and the 1hisF mutant A. baumannii strains. (B) Amount of IL-6
at 6 and 24 h post-infection in BAL fluid from mice lungs (N = 7) infected with
the parental ATCC 17978 and the 1hisF mutant A. baumannii strains.
(C) Total leukocyte counts in BAL fluid from mice lungs infected with the
parental ATCC 17978 and the 1hisF mutant A. baumannii strains, at 6 h
(N = 7) and 24 h (N = 9) post-infection.
of the parental strain but increased the growth rate of the 1hisF
mutant. The mutant showed a growth rate very similar to the
parental strain, thus displaying the later auxotrophy by histidine.
Lungs are particularly susceptible to infection because of the
huge epithelial surface in contact with inspired air. Thus, the
respiratory tract must possess defense mechanisms such as the
anatomical barriers of the nose or the phagocytes in alveoli. The
cytokine IL-6 is involved in regulating inflammatory responses
during bacterial infection, and high IL-6 concentrations are
detected in BAL fluids from patients with pneumonia (Dehoux
et al., 1994). In murine models of pneumonia, IL-6 has been
described as being involved in antibacterial host defense and in
regulating the cytokine network in lungs (van der Poll et al.,
1997). Thus, the acute pulmonary inflammatory response caused
by local exposure to bacterial lipopolysaccharide is regulated by
inflammatory mediators such as IL-6.
In this study, immunoassays performed to detect the cytokine
IL-6 in macrophages RAW 264.7 infected with the parental and
the mutant strains, indicated that the macrophages differentially
secreted IL-6 at 2 h (p < 0.01). In this model of in vitro
infection the mutant strain was able to induce faster the IL-6
secretion, starting the pro-inflammatory response before than
the parental strain. However, at 6 and 20 h, the IL-6 levels
secreted by macrophages RAW 264.7 were similar in infections
caused by both strains (Figure 2A). Thus, the increase of AICAR
biosynthesis is involved in a delayed IL-6 secretion. ELISA
analysis of BAL fluids from the murine pneumonia model
revealed that the IL-6 concentration was higher in BAL fluids
from mice infected with the 1hisF mutant strain than in those
infected with the parental strain (p < 0.001) at 24 h post-
infection, whereas, no significant difference was were observed
in murine BAL fluids obtained at an earlier stage post-infection
(6 h) (Figure 2B).
IL-6 is one of the most discriminative markers for definition
and evaluation of recovery in patients with pneumonia, being
the serum levels of IL-6 in mild or severe pneumonia infections
higher (de Brito et al., 2016). During the initial phases of
pneumonia, alveolar macrophages produce a variety of pro-
inflammatory cytokines such as IL-6, whose role is to both
attract and activate polymorphonuclear leukocytes, necessary for
local bacterial defense and clearance (Bordon et al., 2013). Thus,
noticing an increase of IL-6 secretion in the infection of the1hisF
mutant, we performed a study of leukocytes recruitment in lung
infection caused by the parental ATCC 17978 and the 1hisF
mutant strains. Leukocyte counts in BAL fluids obtained from the
lungs of mice infected with the 1hisF mutant were almost two
times higher than in those infected with the parental strain (p <
0.001) at 24 h (Figure 2C). Microscopic visualization also allowed
identifying the different types of leukocytes. However, although
differences were found in the total number of leukocytes in the
infections, no differences were observed between each cell type in
infections caused by the parental (neutrophils 69%, lymphocytes
16%, macrophages 8%, eosinophils 6%, or basophils 1%) and the
mutant strain (neutrophils 61%, lymphocytes 26%, macrophages
3%, eosinophils 7%, or basophils 3%). In contrast to the infection
in macrophages, which showed differences at the very early
stage post-infection, in the pneumonia model the significant
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differences were observed at 24 h post-infection, both in IL-6
production and in leukocyte cells counts. Thus, expression and
recruitment of cytokines take longer in the in vivo model of
infection than in the in vitromodel of cultured macrophages.
In order to correlate with protection, IL-6 measured by
ELISA was compared with the implication of hisF and AICAR
in phagocytic activity assays. As illustrated in Figure 3A, there
was higher phagocytosis of the 1hisF mutant strain (28%
phagocytosis) than of the parental strain (14%, p < 0.01).
The protective effect of HisF was confirmed in assays with
the A. baumannii strains carrying the plasmid pWH1266-
Km. Thus, the 1hisF + pWH1266-Km mutant showed more
susceptibility to macrophages (39% phagocytosis) that the ATCC
17978 + pWH1266-Km (6%, p > 0.01), concordantly with the
previous result. Relevantly the complementation with the hisF
gene increased the resistance to the phagocytosis, the 1hisF
complemented strain showed very similar number of viable
bacteria (2% phagocytosis) to the ATCC 17978+ pWH1266-Km
strain (Figure 3B). Finally, significant phagocytosis protection
was observed when AICAR at 1mM was used in the assays
with the 1hisF + pWH1266-km mutant showing phagocytosis
percentages similar to those of the parental ATCC 17978 in
absence of AICAR (Figure 3A). Thus, it is clear than both the
genetic complementation with the hisF gene or the AICAR
addition to the culture medium, increase the resistance to
macrophages of the A. baumannii strain with the inactivated
hisF gene.
The results of infection of RAW 264.7 macrophages and of in
vivo pneumonia experiments using the parental and the isogenic
mutant strains suggested that HisF participates in the early
and acute inflammatory responses and host defense against A.
baumannii infection, inhibiting initiation of the innate immune
FIGURE 3 | In vitro phagocytosis assays with macrophages RAW 264.7.
(A) Per cent killing of A. baumannii ATCC 17978, the 1hisF mutant, and the
1hisF mutant in presence of AICAR 1mM (N = 6). (B) Per cent killing of
A. baumannii ATCC 17978 + pWH1266-Km (empty plasmid), the 1hisF +
pWH1266-Km, and the 1hisF complemented strains (N = 6).
cell recruitment in lungs. Moreover, the data obtained in this
study suggest that conversion of PRFAR by the heterodimeric
protein HisHF, in ImGP and AICAR, plays a key role in
lung infection caused by A. baumannii. AICAR expression,
which is involved in AMPK phosphorylation, can be used by
the bacteria to reduce the host immune response and favor
infection. The role of AICAR and AMPK in inflammation
has previously been described (Jhun et al., 2004; Peairs et al.,
2009), although AICAR is known to exert various other effects
such as regulation of cell proliferation and apoptosis, via both
AMPK-dependent and independent mechanisms (Campàs et al.,
2003; López et al., 2003). The adenosine kinase inhibitor 5
′
-
iodotubercidin has been used to prevent the AICAR-mediated
inhibition of inflammation cascade signaling, suggesting that
AMPK activation may be considered a potential therapeutic
target in inflammatory diseases (Peairs et al., 2009).
Significant differences between the wild-type and the 1hisF
mutant strains were observed in relation to survival in themurine
pneumonia model, but not in the sepsis model. Inactivation
of the hisF gene led to disappearance of A. baumannii-
associated virulence, which did not happen in the bacteraemia
model. This can be attributed to the differences between
the local and the systemic inflammation due to the immune
response. The importance of pro-inflammatory cytokines in
host defense during pneumonia, which have different roles
in local inflammation than in the systemic compartment,
has been well-described (Schultz and Poll, 2005; Madigan
et al., 2014). Neutrophils are the first inflammatory cells to
arrive at the infection site, attracted by chemoattractants such
as interleukins. Neutrophils ingest the damaged cells and
also attract macrophages, which carry out phagocytosis. The
macrophages release inflammation-inducing cytokines, such as
IL-1 or IL-6, which increase vascular permeability, swelling,
and local heat. As a result, the pathogen is rapidly located
and destroyed by the recruited macrophages and neutrophils.
However, in bacteraemia models, the infection is not localized,
leading to extended systemic inflammation. Septic shock occurs
when the inflammatory response disseminates inflammatory cells
and mediators through the circulatory and lymphatic systems.
Thus, although local production of pro-inflammatory cytokines
contributes greatly to host defense during local infections in the
lung, the excessive production of pro-inflammatory cytokines
at the systemic level causes organ failure and death in animal
models (Schultz and Poll, 2005; Madigan et al., 2014). We suggest
that the different virulence phenotypes found in both infection
models are at least partly due to the different consequences of the
pro-inflammatory interleukin-mediated inflammatory processes.
To the best of our knowledge, this is the first study describing
the interplay between HisF and the innate immune response
in lungs during bacterial pathogenesis. Further studies and
detailed analysis of the inflammatory response are needed for
a better understanding of the role of HisF in the A. baumannii
pathogenesis and host defense.
In conclusion, the study findings demonstrated that the
lack of HisF in the pneumonia infection of immunocompetent
BALB/c mice caused by ATCC 17978 A. baumannii induces
a sub-lethal infection. Complementation with the original hisF
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gene in the 1hisF mutant increased its virulence in the
experimental pneumonia model. HisF is involved in inhibition
of the recruitment of innate immune cells, as well as in
the production of the proinflammatory cytokine IL-6. Thus,
the hisF gene from A. baumannii ATCC 17978, which is
over-expressed during the course of a pneumonia infection,
is essential for full virulence of the strain in lung infection.
The hisF gene is therefore an alternative and useful tool
for future pathogenesis studies of A. baumannii-associated
pneumonia and for identifying and characterizing important
virulence factors, and it thus represents a potential target
for evaluating new antimicrobial therapies. In light of the
study findings, expression of the hisF gene seems to decrease
the innate immunity and the inflammatory responses, which
may partly explain the ability of the pathogen to persist in
the lung.
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